KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS

The review presents main provisions of the new recommendations of the European communities on the management of dyslipidemia (DLP). The emphasis on the economic component of the prevention of cardiovascular disease (CVD) is made, four groups of patients with levels of risk from very high to low, the...

Full description

Bibliographic Details
Main Author: M. G. BUBNOVA
Format: Article
Language:Russian
Published: Remedium Group LLC 2016-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/1622
_version_ 1797842072278925312
author M. G. BUBNOVA
author_facet M. G. BUBNOVA
author_sort M. G. BUBNOVA
collection DOAJ
description The review presents main provisions of the new recommendations of the European communities on the management of dyslipidemia (DLP). The emphasis on the economic component of the prevention of cardiovascular disease (CVD) is made, four groups of patients with levels of risk from very high to low, the target values of blood lipids and the importance of specific lipids and lipoproteins to determine the risk, analysis of the DLP type and goals of lipid-lowering therapy are determined. The review considers indications for prescription of statins and combination lipid-lowering therapy.
first_indexed 2024-04-09T16:41:48Z
format Article
id doaj.art-e640d108abf04171b1219fb29edde7a9
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:41:48Z
publishDate 2016-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-e640d108abf04171b1219fb29edde7a92023-04-23T06:56:39ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-01019122010.21518/2079-701X-2016-19-12-201613KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTSM. G. BUBNOVA0State Scientific and Research Center of Preventive Medicine of the Ministry of Health of RussiaThe review presents main provisions of the new recommendations of the European communities on the management of dyslipidemia (DLP). The emphasis on the economic component of the prevention of cardiovascular disease (CVD) is made, four groups of patients with levels of risk from very high to low, the target values of blood lipids and the importance of specific lipids and lipoproteins to determine the risk, analysis of the DLP type and goals of lipid-lowering therapy are determined. The review considers indications for prescription of statins and combination lipid-lowering therapy.https://www.med-sovet.pro/jour/article/view/1622cardiovascular risklipid-lowering therapystatins.
spellingShingle M. G. BUBNOVA
KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
Медицинский совет
cardiovascular risk
lipid-lowering therapy
statins.
title KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
title_full KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
title_fullStr KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
title_full_unstemmed KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
title_short KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS
title_sort key provisions of the new 2016 european guidelines for management of dyslipidemias and comments
topic cardiovascular risk
lipid-lowering therapy
statins.
url https://www.med-sovet.pro/jour/article/view/1622
work_keys_str_mv AT mgbubnova keyprovisionsofthenew2016europeanguidelinesformanagementofdyslipidemiasandcomments